197 related articles for article (PubMed ID: 27696562)
21. First case report of Cryptococcus laurentii knee infection in a previously healthy patient.
Huang H; Pan J; Yang W; Lin J; Han Y; Lan K; Zeng L; Liang G; Liu J
BMC Infect Dis; 2020 Sep; 20(1):681. PubMed ID: 32943003
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis.
Lutz JE; Clemons KV; Stevens DA
J Antimicrob Chemother; 2000 Sep; 46(3):437-42. PubMed ID: 10980171
[TBL] [Abstract][Full Text] [Related]
23. Infections due to non-neoformans cryptococcal species.
McCurdy LH; Morrow JD
Compr Ther; 2003; 29(2-3):95-101. PubMed ID: 14606338
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA
Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review.
Bernal-Martinez L; Gomez-Lopez A; Castelli MV; Mesa-Arango AC; Zaragoza O; Rodriguez-Tudela JL; Cuenca-Estrella M
Med Mycol; 2010 Feb; 48(1):90-6. PubMed ID: 19235546
[TBL] [Abstract][Full Text] [Related]
26. In vitro combination between antifungals and diphenyl diselenide against Cryptococcus species.
Rossato L; Loreto ES; Venturini TP; de Azevedo MI; Al-Hatmi AMS; Santurio JM; Alves SH
Mycoses; 2019 Jun; 62(6):508-512. PubMed ID: 30776159
[TBL] [Abstract][Full Text] [Related]
27. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
Chayakulkeeree M; Tangkoskul T; Waywa D; Tiengrim S; Pati N; Thamlikitkul V
J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.
Clemons KV; Lutz JE; Stevens DA
Antimicrob Agents Chemother; 2001 Mar; 45(3):686-9. PubMed ID: 11181343
[TBL] [Abstract][Full Text] [Related]
29. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.
Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA
Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471
[TBL] [Abstract][Full Text] [Related]
30. Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.
Bauters TG; Swinne D; Boekhout T; Noens L; Nelis HJ
Mycopathologia; 2002; 153(3):133-5. PubMed ID: 11998874
[TBL] [Abstract][Full Text] [Related]
31. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Gazzoni AF; Capilla J; Mayayo E; Guarro J
Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Kantarcioğlu AS; Boekhout T; Yücel A; Altas K
Med Mycol; 2009 Mar; 47(2):169-76. PubMed ID: 18654925
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
[TBL] [Abstract][Full Text] [Related]
35. Severe primary cutaneous Cryptococcus gattii causing ulcerative cellulitis in an immunocompetent patient.
Tan GSE; Singh R; Chong TYR; Su PQ; Lee JSS; Wong KJH; Tan JWL; Vasoo S
Lancet Infect Dis; 2019 Oct; 19(10):1148. PubMed ID: 31559968
[No Abstract] [Full Text] [Related]
36. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.
Treviño-Rangel Rde J; Villanueva-Lozano H; Hernández-Rodríguez P; Martínez-Reséndez MF; García-Juárez J; Rodríguez-Rocha H; González GM
Med Mycol; 2016 Mar; 54(3):280-6. PubMed ID: 26705833
[TBL] [Abstract][Full Text] [Related]
37. Cryptococcus laurentii fungemia in a low birth weight preterm neonate: India.
Gupta M; Mishra AK; Singh SK
J Infect Public Health; 2018; 11(6):896-897. PubMed ID: 29731340
[TBL] [Abstract][Full Text] [Related]
38. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
[No Abstract] [Full Text] [Related]
39. Cryptococcus albidus Fungemia in an Immunosuppressed Child: Case Report and Systematic Literature Review.
Choe YJ; Blatt DB; Yalcindag A; Geffert SF; Bobenchik AM; Michelow IC
J Pediatric Infect Dis Soc; 2020 Feb; 9(1):100-105. PubMed ID: 31183496
[TBL] [Abstract][Full Text] [Related]
40. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
